AzTrials
AzTrials

Chronic Low Back Pain (CLBP)Phase 2RESTNCT07298941

Resilience Enhancement Following Sleep Treatment

A Phase 2 study testing Cognitive-behavioral therapy for insomnia (CBTi), CBTi + Savoring Meditation and CBTi + Pain Education in people with Chronic Low Back Pain (CLBP) and Insomnia, run by University of Virginia at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The primary objective of this study is to evaluate the efficacy of an adaptive intervention targeting both insomnia and positive affect in improving pain outcomes for adults with chronic low back pain (cLBP) and comorbid insomnia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Low Back Pain (CLBP), Insomnia
What is being tested?
Cognitive-behavioral therapy for insomnia (CBTi), CBTi + Savoring Meditation and CBTi + Pain Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteUnited States
Study dates
16 Dec 2025to 30 Apr 2030
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age >=18 years; (2) report low back pain as ongoing problem >= 3 months and any pain on at least half of the days over the past 6 months (consistent with NIH Consensus Recommendations, other chronic pain problems can be present, but cLBP must be reported as primary); (3) average pain intensity >= 4 over past 7 days on a 0-10 numerical rating scale; (4) sleep-onset insomnia and/or sleep maintenance insomnia and/or late insomnia (>30 minutes of WASO or SOL or waking >30 minutes before desired time for at least 3 nights/week) with presence of insomnia symptoms for >= 6 months, and the sleep disturbance (or associated daytime fatigue) must cause significant distress or impairment in social, occupational, or other areas of functioning to be consistent with DSM 5 criteria (evaluated by phone interview).

Who cannot join

  • currently receiving behavioral treatment for insomnia; (2) currently engaging in formal or informal meditation practice on a regular (e.g., weekly) basis; (3) unstable medication use for sleep, pain, or other indication (e.g., changed within the past 3 months); (4) irregular sleep schedules dictated by shift work (i.e., usual bedtimes outside 8:00 p.m.-2:00 a.m. or arising time outside 4:00 a.m.-10:00 a.m.); (4) mental health condition deemed to interfere with study procedures or put the participant at undue risk via semi-structured interview (e.g., screen positive for psychotic disorder) or other untreated sleep disorders (e.g., obstructive sleep apnea, restless legs syndrome) as evaluated by our semi-structured interview based on the Diagnostic Interview for Insomnia (DII); (5) do not have regular internet access; (6) cannot read and speak English (interventions only available in English); and (7) severe cognitive impairment (i.e., score =9 on the Telephone-Assessed Mental State); (8) currently pregnant; 9) unable or unwilling to comply with study protocols, or otherwise determined by the PI to be able to safely participate in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • University of Virginia

    Charlottesville, Virginia, 22903

    Patrick Finan, Ph.D., 4349822281, finanlab@uvahealth.org

    Patrick Finan, Ph.D.

    Recruiting

Other trials in United States

About this study

Official title: An Adaptive Intervention to Improve Pain Outcomes Following Cognitive Behavioral Therapy for Insomnia in Patients With Comorbid Chronic Low Back Pain and Insomnia

The primary objective of this study is to evaluate the efficacy of an adaptive intervention targeting both insomnia and positive affect in improving pain outcomes for adults with chronic low back pain (cLBP) and comorbid insomnia. Specifically, the study tests whether augmenting a cognitive behavioral therapy for insomnia (CBTi) program with a meditation intervention (Savoring Meditation) or a Pain Education intervention will result in greater reductions in pain intensity.

Secondary objectives include evaluating improvements in insomnia severity, positive and negative affect, and overall quality of life.

Being tested
Cognitive-behavioral therapy for insomnia (CBTi), CBTi + Savoring Meditation, CBTi + Pain Education
Keywords
chronic low back pain, insomnia, cognitive-behavioral therapy for insomnia, meditation, savoring, pain, internet intervention
Medical subject headings
Sleep Initiation and Maintenance Disorders, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive-behavioral therapy for insomnia (CBTi)Behavioural

    Sleep Healthy Using the Internet (SHUTi) is a 9-week self-guided, automated, internet-based program that is tailored to the individual and designed to recapitulate the core features of face-to-face CBTi (sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, relapse prevention). It is fully accessible as a web-based application via computers, tablets, and smartphones.

  • CBTi + Savoring MeditationBehavioural

    After first completing CBTi, participants will then complete a course of Savoring Meditation, a meditation training program focused on generating and maintaining positive emotions. Savoring Meditation training comprises four 30-minute training sessions (20-minute meditation training and 10 minutes for Q\&A and session debrief), and will be delivered 1-on-1 by a trained interventionist over remote video-conference.

  • CBTi + Pain EducationBehavioural

    After first completing the full course of CBTi, participants will then complete a Pain Education intervention. Delivered 1-on-1 via telehealth, patients will be introduced to the biopsychosocial model of pain, through which they will learn about 1) biological bases for low back pain and chronic pain in general, 2) psychological and 3) social processes that influence pain perception, and 4) pain self-management strategies that are supported by scientific evidence. Pain Education training comprises four 30-minute training sessions.

Study groups in NCT07298941
Study groupRoleWhat they receive
Cognitive-Behavioral Therapy for InsomniaOtherOpen Label CBTi
Receives: Behavioral: Cognitive-behavioral therapy for insomnia (CBTi)
Cognitive-Behavioral Therapy for Insomnia plus Savoring MeditationExperimentalOpen label CBTi followed by random allocation to Savoring Meditation
Receives: Behavioral: CBTi + Savoring Meditation
Cognitive-Behavioral Therapy for Insomnia plus Pain EducationActive comparatorOpen label CBTi followed by random allocation to Pain Education
Receives: Behavioral: CBTi + Pain Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Severity

    0-10 pain severity item from the PEG

    Measured: Baseline to post-intervention (11 weeks)

Secondary outcomes (5)
  1. Pain Severity

    0-10 pain severity item from the PEG

    Measured: Baseline to 6 months follow-up

  2. Pain Severity

    0-10 pain severity item from the PEG

    Measured: Baseline to 12 month follow-up

  3. Pain Interference

    Pain interference items from the PEG

    Measured: Baseline to Post-Intervention (11 weeks), 6 month follow-up, 12 month follow-up

  4. Disability

    Oswestry Disability Index

    Measured: Baseline to Post-Intervention (11 weeks), 6 month follow-up, 12 month follow-up

  5. Insomnia Severity

    Insomnia Severity Index

    Measured: Baseline to Post-Intervention (11 weeks), 6 month follow-up, 12 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2025
  2. Study start16 Dec 2025
  3. Primary completion30 Oct 2029 (estimated)
  4. Study completion30 Apr 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Sequential
Model description
Adaptive Clinical Trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07298941
Sponsor's protocol ID
SBS-7457
Other IDs
R01AT013240
Acronym
REST
Status last verified
Dec 2025
First submitted
19 Dec 2025
Last updated
23 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We will consider data sharing requests on a case by case basis, as dictated by institutional data sharing agreements.

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Cognitive-behavioral therapy for insomnia (CBTi), CBTi + Savoring Meditation and CBTi + Pain Education in people with Chronic Low Back Pain (CLBP) and Insomnia, run by University of Virginia at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zayn Shahzad (434-243-5906, finanlab@uvahealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Severity (time frame: Baseline to post-intervention (11 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in